SARS-CoV-2 vaccine breakthrough infections among healthcare workers in a large Belgian hospital network
Infect Control Hosp Epidemiol
.
2022 Nov;43(11):1755-1757.
doi: 10.1017/ice.2021.326.
Epub 2021 Jul 22.
Authors
Dieter Geysels
1
,
Pierre Van Damme
2
,
Walter Verstrepen
1
,
Peggy Bruynseels
1
3
,
Bea Janssens
4
,
Patrick Smits
5
,
Reinout Naesens
1
3
Affiliations
1
Department of Medical Microbiology, ZiekenhuisNetwerk Antwerpen, B-2020Antwerp, Belgium.
2
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, B-2610Wilrijk, Belgium.
3
Department of Infection Prevention and Control, ZiekenhuisNetwerk Antwerpen, B-2020Antwerp, Belgium.
4
IDEWE, External Service for Prevention and Protection at Work, B-2000Antwerp, Belgium.
5
Agency for Care and Health, Prevention Division, Flanders, B-2018Antwerp, Belgium.
PMID:
34289927
PMCID:
PMC8314186
DOI:
10.1017/ice.2021.326
No abstract available
MeSH terms
Belgium / epidemiology
COVID-19 Vaccines
COVID-19* / prevention & control
Health Personnel
Hospitals
Humans
SARS-CoV-2
Substances
COVID-19 Vaccines